Please login to the form below

Not currently logged in
Email:
Password:

Dr Catherine Strader joins Acorda Therapeutics’ board

She brings experience from Merck & Co and Synergy Partners R&D Solutions

Acorda Therapeutics has expanded its board of directors with the addition of Dr Catherine Strader.

Dr Strader is currently a founding partner at Synergy Partners R&D Solutions, and prior to co-founding the drug discovery and development network in 2014 was vice president and discovery site head at Merck & Co's New Jersey hub.

She also brings executive leadership experience from Schering-Plough, where she served as executive vice president of discovery research and chief scientific officer between 2002 and 2007.

Dr Ron Cohen, Acorda's president and chief executive officer, said: “Catherine brings decades of experience as both a drug developer and biopharmaceutical business executive with an outstanding track record of achievement.

“I expect her to add significant value to the board and the company as we continue to develop our pipeline and grow our business.”

23rd February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...

Infographics